[1]
J. E. A. . Molina, “Understanding The Role of SGLT2 Inhibitors in Cardiovascular Risk Reduction for Type 2 Diabetes Patients-A Literature Review”, International Journal Of Medical Science And Clinical Research Studies, vol. 4, no. 03, pp. 524–537, Mar. 2024.